Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study-Reference-Cited by-同舟云学术

Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study

Published:2018-02-15 Issue:5 Volume:25 Page:1176-1183
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kim In-Hwan,Park Sung-Soo,Lee Chang-Min,Kim Min Chan,Kwon In-Kyu,Min Jae-Seok,Kim Hyoung-Il,Lee Han Hong,Lee Sang-Il,Chae Hyundong

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-018-6375-z/fulltext.html

Reference34 articles.

1. Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Modern surgery for gastric cancer: Japanese perspective. Scand J Surg. 2006;95:232–5.

2. Gallo A, Cha C. Updates on esophageal and gastric cancers. World J Gastroenterol. 2006;12:3237–42.

3. Gunderson LL. Gastric cancer-patterns of relapse after surgical resection. Semin Radiat Oncol. 2002;12:150–61.

4. Paoletti X, Oba K, Burzykowski T, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010;303:1729–37.

5. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fewer Feedback Opportunities and Health Perception of Gastric Cancer Survivors: Opportunities for Patient Education;Journal of Cancer Education;2024-05-21

2. Adjuvant chemotherapy for stage II and III gastric adenocarcinoma: A retrospective analysis with long-term follow-up;Journal of the Formosan Medical Association;2024-05

3. Comparison of adjuvant capecitabine plus oxaliplatin (CAPOX) versus S-1 after gastrectomy: a population-based cohort study using a nationwide claims database;Scientific Reports;2023-10-11

4. Treatment Outcomes of Stage II or III Gastric Cancer Treated with Adjuvant Chemotherapy with TS-1 or XELOX after Radical Surgery;Hong Kong Journal of Radiology;2023-06-08

5. Comparison of adjuvant capecitabine plus oxaliplatin (CAPOX) versus S-1 in patients with gastric cancer after gastrectomy: A nationwide cohort study based on the National Health Insurance Service (NHIS) database in Korea;2023-05-09